Latest molecular technologies Stories
ZaBeCor Pharmaceuticals ("ZaBeCor") announces today the formation of its new subsidiary Biothorpe Pharmaceuticals ("Biothorpe" or the "Company"), a biotechnology company focused on the development of siRNA, antisense and other molecular technologies for the treatment of cancer. Recent studies in academia and in the biopharmaceutical industry indicate that Syk kinase is required for the proliferation of malignant cells in several cancers. Biothorpe's intellectual property portfolio includes...
- An evil spirit; a devil.
- A nightmare.